Technical Glossary: Peptide Chemistry, Pharmacokinetics, and Research Documentation Terms

The following glossary defines terms used in synthetic peptide chemistry, analytical characterization, pharmacological profiling, and research documentation. Definitions are written for investigators with postgraduate-level training in chemistry, pharmacology, or molecular biology. This reference is structured to support protocol design, CoA interpretation, and vendor evaluation in a preclinical research context.

Analytical Chemistry Terms

• Net Peptide Content (NPC): The fraction of the stated mass of a peptide sample that corresponds to actual peptide, after accounting for water (typically 5–15% w/w by Karl Fischer titration) and counterion mass (TFA contributes 114 Da per molecule; acetate contributes 59 Da). NPC is measured by amino acid analysis (AAA) after acid hydrolysis (6M HCl, 110°C, 24h) or quantitative UV at 280 nm for sequences containing Trp or Tyr. A lot with 85% NPC delivers 15% less active compound per stated weight.
• HPLC Purity (RP-HPLC, 214 nm): Main component peak area as a percentage of total integrated peak area in a reversed-phase HPLC chromatogram with UV detection at 214 nm (amide bond absorption). This quantifies the proportion of the main species relative to all UV-detectable impurities including deletion sequences, truncations, and oxidation products. Specification of ≥99% is standard for quantitative preclinical research.
• ESI-MS (Electrospray Ionization Mass Spectrometry): Ionization method that generates multiply charged ions ([M+nH]ⁿ⁺) from peptides in solution. The deconvoluted (charge-state resolved) mass should match theoretical monoisotopic mass within ±0.5 Da for peptides <2,000 Da. Used for identity confirmation as a complement to HPLC purity data. Does not substitute for purity determination.
• MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization Time-of-Flight): MS method producing singly charged [M+H]⁺ ions from crystallized peptide-matrix mixtures. Provides rapid identity confirmation; mass accuracy is typically 0.01–0.1%. Better suited for larger peptides (>2,000 Da) where ESI charge-state deconvolution becomes complex.
• LAL Assay (Limulus Amebocyte Lysate): Endotoxin detection method exploiting the cascade activation of horseshoe crab coagulation factors by bacterial lipopolysaccharide (LPS). Chromogenic or turbidimetric endpoint. Acceptance criterion for research peptides in cell culture: ≤1 EU/mg. Cationic peptides may interfere with LAL gelation, requiring spike-recovery validation at the test concentration.
• Karl Fischer Titration: Coulometric or volumetric water content determination using iodine-mediated oxidation of SO₂ by water. Provides % w/w water in lyophilized peptide samples. Required for NPC calculation.
• SEC-HPLC (Size Exclusion Chromatography HPLC): Fractionation by hydrodynamic volume. Used to quantify aggregate content in peptide samples. Aggregates co-eluting with main peak in RP-HPLC are resolved by SEC, identifying samples with fibril or oligomer formation that could confound biological assay results.

Pharmacological and Kinetic Terms

• K_D (Equilibrium Dissociation Constant): Thermodynamic measure of receptor-ligand binding affinity. Equal to k_off/k_on. Lower K_D values indicate higher affinity. Measured by equilibrium radioligand displacement, SPR (surface plasmon resonance), or TR-FRET assays.
• IC50: Concentration of inhibitor (or competing ligand) that displaces 50% of radioligand binding at a defined receptor concentration. Related to K_i by the Cheng-Prusoff equation when competing against a known radioligand at its K_D concentration.
• EC50: Concentration producing 50% of maximal functional response (e.g., 50% of maximal cAMP accumulation, Ca²⁺ flux, or reporter gene activation). Context-dependent: agonist EC50 at a GPCR may differ substantially from K_D due to receptor reserve effects and G protein amplification.
• Biased Agonism (Functional Selectivity): Differential activation of downstream signaling pathways from the same receptor by different ligands. A GPCR ligand may preferentially activate G protein-mediated cAMP accumulation over β-arrestin recruitment (G-biased) or vice versa (β-arrestin-biased). Quantified by Δlog(τ/KA) calculations comparing signaling pathway activation profiles relative to a reference agonist.
• Plasma Half-Life (t½): Time for plasma concentration to decrease by 50% after i.v. administration. For linear peptides, determined primarily by proteolytic degradation (serine proteases, DPP-4, NEP), renal filtration (for MW <5 kDa), and hepatic first-pass metabolism.
• Receptor Occupancy: Fraction of receptors bound by ligand at equilibrium, determined by the law of mass action: occupancy = [L]/(K_D + [L]). Full occupancy (99%) requires ligand concentrations approximately 100-fold above K_D.

Synthesis and Formulation Terms

• Fmoc-SPPS (Fluorenylmethyloxycarbonyl Solid-Phase Peptide Synthesis): The dominant method for research peptide production. Fmoc provides base-labile (piperidine, 20%) N-terminal protection; acid-labile (TFA/scavengers) side-chain protection is removed during cleavage from resin. Enables synthesis of sequences up to ~50 residues with high coupling efficiency (>99.5% per step by quantitative Fmoc release).
• Resin Loading: Millimoles of first amino acid per gram of resin (mmol/g). Determines theoretical synthesis scale and influences deletion sequence frequency — higher loadings increase density of growing chains and may increase epimerization and coupling failures for hindered residues.
• Counterion: The anionic salt form associated with a peptide's basic residues (Lys, Arg, His) following purification. TFA (trifluoroacetate) is the default counterion from Fmoc-SPPS/TFA cleavage; acetate is preferred for cell-based assays as TFA can be cytotoxic at concentrations >0.1 mM. Ion exchange from TFA to acetate is performed by lyophilization from dilute acetic acid solution or ion-pair RP-HPLC with ammonium acetate mobile phase.
• Lyophilization (Freeze-Drying): Removal of water from frozen solutions by sublimation under vacuum. Produces a fluffy, hygroscopic powder (lyophilate) with residual moisture typically 1–8% w/w. Lyophilized peptides are more stable than solutions and suitable for long-term storage at −20°C.

Documentation Terms

• Certificate of Analysis (CoA): Formal quality release document issued by the manufacturing or QC authority for each production lot. Should report all specifications tested with numerical results and pass/fail determination against predetermined acceptance criteria.
• Lot Number: A unique alphanumeric identifier linking a specific package of material to its manufacturing batch record, analytical records, and quality release decision. Alpha Nordisk lot format: A[year][Q][quarter][peptide code][batch sequence] — e.g., A26Q2BPC0612.
• Lot-to-Lot Consistency: Quantitative agreement of analytical parameters (HPLC purity, NPC, MS mass, endotoxin) between independently manufactured lots of the same peptide. Required for reproducible multi-experiment research programs. Typically assessed by comparing all quantitative CoA parameters across ≥3 consecutive lots.

Alpha Nordisk presents this content for research documentation purposes. All products referenced are for research and laboratory use only. Not for unsupervised human consumption.